- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/173 - Purine radicals with 2-deoxyribosyl as the saccharide radical
Patent holdings for IPC class C07H 19/173
Total number of patents in this class: 271
10-year publication summary
|
17
|
11
|
17
|
18
|
14
|
17
|
12
|
15
|
21
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2247 |
18 |
| Agilent Technologies, Inc. | 2639 |
10 |
| Merck Sharp & Dohme LLC | 3733 |
9 |
| Alnylam Pharmaceuticals, Inc. | 1181 |
7 |
| Illumina Cambridge Limited | 696 |
7 |
| Nucana plc | 74 |
7 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 312 |
6 |
| Illumina, Inc. | 3538 |
6 |
| ViiV Healthcare Company | 164 |
5 |
| Janssen Biopharma, Inc. | 32 |
5 |
| Ajinomoto Co., Inc. | 2284 |
4 |
| Alios BioPharma, Inc. | 60 |
4 |
| CARIS Science, Inc. | 71 |
4 |
| The Scripps Research Institute | 1345 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| Janssen Pharmaceuticals, Inc. | 430 |
3 |
| Massachusetts Institute of Technology | 10305 |
3 |
| Centrillion Technology Holdings Corporation | 51 |
3 |
| Idenix Pharmaceuticals LLC | 58 |
3 |
| Ionis Pharmaceuticals, Inc. | 958 |
3 |
| Other owners | 157 |